药使用和急性损伤风险:对日本医院数据库的分析
Satoru Mitsuboshi1, Masami Tsuchiya2, Hayato Kizaki2
1Department of Pharmacy, Kaetsu Hospital, Niigata, Japan; Division of Drug Informatics, Keio University Faculty of Pharmacy, Tokyo, Japan.
The Journal of pharmacology and experimental therapeutics
|March 10, 2026
概括
这项研究发现,与氧化相比,在使用不同类型的药 (包括lubiprostone, senna和linaclotide) 的患者中,急性损伤 (AKI) 风险没有显著差异. 这些发现表明药选择可能不会影响AKI风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 胃肠病学 胃肠病学
- 药理学 药理学是指药理学的学科.
背景情况:
- 松剂使用与急性损伤 (AKI) 之间的潜在联系需要进一步调查.
- 了解不同药类别中AKI的比较风险对于患者安全至关重要.
研究的目的:
- 调查使用特定的药 (卢比,林纳克洛提德,塞纳,氧化) 与发展AKI的风险之间的关联.
- 为了比较与分泌药物,刺激性药和非吸收物质相关的AKI风险.
主要方法:
- 使用JMDC医院行政索赔数据库 (2014年4月至2022年8月) 进行的回顾性队列研究.
- 定义的药包括 lubiprostone, linaclotide (分泌), senna (兴奋剂) 和氧化 (未被吸收).
- AKI诊断遵循病:改善全球结果 (KDIGO) 标准;使用了考克斯回归分析.
主要成果:
- 包括159,630名患者;不同组的AKI发病率各不相同.
- 考克斯回归显示,与氧化相比,lubiprostone (aHR,0.96), senna (aHR,1.08),或linaclotide (aHR,1.42) 的AKI风险没有统计显著降低.
- 调整后的危险比率表明,这些药对AKI发展没有保护作用.
结论:
- 该研究发现,在使用 lubiprostone, senna, linaclotide 或氧化的患者中,急性损伤风险没有显著差异.
- 这些发现表明,在这些药物中选择药可能不会显著影响发展AKI的风险.
- 进一步的研究可能是有必要的,以证实这些发现在不同的人群和临床环境.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
437
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
437
Acute Kidney Injury I: Introduction
1.0K
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
1.0K
Acute Kidney Injury VI: Nursing Management
624
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
624
Acute Kidney Injury II: Pathophysiology
1.6K
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
1.6K
Acute Kidney Injury V: Interprofessional Care
438
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
438
Acute Kidney Injury III: Clinical Manifestations
1.2K
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
1.2K


